Skip to main content
Premium Trial:

Request an Annual Quote

IP Update: Genepeeks, The Chinese University of Hong Kong, among Recent Bioinformatics Patent Winners


Title: Method and system for generating a virtual progeny genome

US Patent Number: 8,620,594

Assignee: GenePeeks

Inventors: Lee Silver

Title: Size-based genomic analysis

US Patent Number: 8,620,593

Assignee: The Chinese University of Hong Kong

Inventors: Dennis Yuk Ming Lo, Kwan Chee Chan, Wai Kwun Rossa Chiu, Wenli Zheng

Title: Methods for analyzing high dimensional data for classifying, diagnosing, prognosticating, and/or predicting diseases and other biological states

US Patent Number: 8,620,592

Assignee: Department of Health and Human Services

Inventors: Javed Khan, Markus Ringner, Carsten Peterson, Paul Meltzer

Title: Synthetic binding proteins

US Patent Number: 8,620,589

Assignee: New England Biolabs

Inventors: Richard Morgan

Title: Method, system, and computer program product for determining a putative amino acid sequence

US Patent Number: 8,620,588

Assignee: Shimadzu Research Laboratory

Inventors: Michael May, Jing Wen Yao

Title: Oligomer sequences mapping

US Patent Number: 8,615,365

Assignee: Complete Genomics

Inventors: Aaron Halpern, Igor Nazarenko

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.